SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-21-011027
Filing Date
2021-05-11
Accepted
2021-05-11 16:15:40
Documents
16
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 39255
2 ex99-1.htm EX-99.1 44961
3 ex99-2.htm EX-99.2 77873
4 ex99-1_001.jpg GRAPHIC 4756
  Complete submission text file 0001493152-21-011027.txt   417602

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20210511.xsd EX-101.SCH 3614
6 XBRL DEFINITION FILE hrow-20210511_def.xml EX-101.DEF 27692
7 XBRL LABEL FILE hrow-20210511_lab.xml EX-101.LAB 37836
8 XBRL PRESENTATION FILE hrow-20210511_pre.xml EX-101.PRE 26287
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 5572
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35814 | Film No.: 21911499
SIC: 2834 Pharmaceutical Preparations